Advanced Flower Capital (AFCG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Completed spin-off of commercial real estate portfolio on July 9, 2024, transitioning to a pure-play cannabis lender focused on state-compliant operators.
Q2 2024 GAAP net income was $16.4 million, up from $12.1 million in Q2 2023; distributable earnings were $11.4 million ($0.56 per share).
Declared $1.11 per share in dividends for the first half of 2024, including a $0.15 special dividend related to the spin-off.
Loan portfolio as of June 30, 2024, was $335.4 million in principal, with 44% floating rate exposure.
Focused on reducing underperforming credits, reinvigorating origination, and enhancing underwriting.
Financial highlights
Net interest income for Q2 2024 was $18.4 million; distributable earnings were $11.4 million ($0.56 per share).
Book value per share was $15.21 as of June 30, 2024, down from $15.64 at year-end 2023.
Paid a regular dividend of $0.48 per share and a special dividend of $0.15 per share in July 2024.
Cash and cash equivalents were $170.3 million as of June 30, 2024.
Total assets were $458 million as of June 30, 2024.
Outlook and guidance
Management expects to meet or exceed the $100 million origination target for 2024, with $57.3 million closed year-to-date and two deals in documentation.
Board intends to continue quarterly dividends, targeting 85%-100% payout of distributable earnings annually.
Focus remains on limited license states, proven operators, and continued portfolio diversification.
Plans to raise additional equity and/or debt to support portfolio growth as cannabis legalization expands.
Confident in capitalizing on industry growth opportunities as state-level legalization expands.
Latest events from Advanced Flower Capital
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - BDC conversion expanded investment scope; $31.3M interest income, $0.05 dividend declared.AFCG
Q4 20254 Mar 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025 - Shareholders will vote on director election and auditor ratification, with Board support.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion, new advisory agreement, and leverage increase.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion and new advisory agreement for expanded flexibility.AFCG
Proxy Filing2 Dec 2025 - Vote on director election and auditor ratification at the May 2025 virtual annual meeting.AFCG
Proxy Filing2 Dec 2025